Toggle Main Menu Toggle Search

Open Access padlockePrints

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

Lookup NU author(s): Professor Sir John BurnORCiD, Dr Anne-Marie Gerdes, Dr Mohammad Movahedi, Professor John Mathers


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Burn J, Gerdes AM, Macrae F, Mecklin JP, Moeslein G, Olschwang S, Eccles D, Evans DG, Maher ER, Bertario L, Bisgaard ML, Dunlop MG, Ho JWC, Hodgson SV, Lindblom A, Lubinski J, Morrison PJ, Murday V, Ramesar R, Side L, Scott RJ, Thomas HJW, Vasen HF, Barker G, Crawford G, Elliott F, Movahedi M, Pylvanainen K, Wijnen JT, Fodde R, Lynch HT, Mathers JC, Bishop DT

Publication type: Article

Publication status: Published

Journal: Lancet

Year: 2011

Volume: 378

Issue: 9809

Pages: 2081-2087

Print publication date: 28/10/2011

ISSN (print): 0140-6736

ISSN (electronic): 1474-547X

Publisher: Elsevier


DOI: 10.1016/S0140-6736(11)61049-0

Notes: On behalf of the CAPP2 Investigators


Altmetrics provided by Altmetric


Funder referenceFunder name
Bayer Pharma
Cancer Council of Victoria Australia
Newcastle Hospitals
UK Medical Research Council
Bayer Corporation
Bayer Schering Pharma
European Union
Finnish Cancer Foundation
International Society for Gastrointestinal Hereditary Tumours (InSiGHT)
National Starch and Chemical Co
SIAK Switzerland
THRIPP South Africa
C588/A10589Cancer Research UK